IL130166A0 - Somatostatin antagonists - Google Patents

Somatostatin antagonists

Info

Publication number
IL130166A0
IL130166A0 IL13016697A IL13016697A IL130166A0 IL 130166 A0 IL130166 A0 IL 130166A0 IL 13016697 A IL13016697 A IL 13016697A IL 13016697 A IL13016697 A IL 13016697A IL 130166 A0 IL130166 A0 IL 130166A0
Authority
IL
Israel
Prior art keywords
somatostatin antagonists
antagonists
somatostatin
residue
amino acid
Prior art date
Application number
IL13016697A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/855,204 external-priority patent/US6262229B1/en
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL130166A0 publication Critical patent/IL130166A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL13016697A 1996-12-04 1997-12-04 Somatostatin antagonists IL130166A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3235896P 1996-12-04 1996-12-04
US76067296A 1996-12-04 1996-12-04
US08/855,204 US6262229B1 (en) 1996-12-04 1997-05-13 Somatostatin antagonists
PCT/US1997/022251 WO1998024807A2 (en) 1996-12-04 1997-12-04 Somatostatin antagonists

Publications (1)

Publication Number Publication Date
IL130166A0 true IL130166A0 (en) 2000-06-01

Family

ID=27364103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13016697A IL130166A0 (en) 1996-12-04 1997-12-04 Somatostatin antagonists

Country Status (17)

Country Link
EP (1) EP0956296B1 (ko)
JP (2) JP4124820B2 (ko)
KR (1) KR100479149B1 (ko)
AT (1) ATE330966T1 (ko)
AU (1) AU728224B2 (ko)
BR (1) BR9714376A (ko)
CA (1) CA2274144C (ko)
DE (1) DE69736193T2 (ko)
ES (1) ES2264174T3 (ko)
HU (1) HUP0003396A3 (ko)
IL (1) IL130166A0 (ko)
MX (1) MXPA99004944A (ko)
NZ (1) NZ335879A (ko)
PL (1) PL334089A1 (ko)
RU (1) RU2179172C2 (ko)
TW (1) TW575582B (ko)
WO (1) WO1998024807A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377265A1 (en) * 1999-06-25 2001-01-04 Barry A. Morgan Somatostatin agonists
US6864234B1 (en) 1999-06-25 2005-03-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Somatostatin agonists
JP4204322B2 (ja) 2001-03-08 2009-01-07 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド ソマトスタチンアンタゴニスト
HUP0303727A2 (hu) * 2001-04-09 2004-03-01 The Administrators Of The Tulane Educational Fund Szomatosztatin agonisták és ezek alkalmazása
CA2666642C (en) * 2006-10-16 2015-11-17 The Salk Institute For Biological Studies Receptor(sstr2)-selective somatostatin antagonists
US8691761B2 (en) 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
ES2351569B8 (es) * 2009-05-07 2012-06-20 Bcn Peptides S.A. Ligandos peptídicos de receptores de somatostatina.
WO2011151782A1 (en) 2010-06-02 2011-12-08 Preglem Sa A role for somatostatin to modulate initiation of follicular growth in the human ovary
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
US5708135A (en) * 1995-09-29 1998-01-13 Biomeasure Incorporated Cyclic peptide analogs of somatostatin

Also Published As

Publication number Publication date
ATE330966T1 (de) 2006-07-15
JP4264762B2 (ja) 2009-05-20
TW575582B (en) 2004-02-11
CA2274144C (en) 2004-03-30
ES2264174T3 (es) 2006-12-16
AU728224B2 (en) 2001-01-04
WO1998024807A2 (en) 1998-06-11
DE69736193T2 (de) 2007-05-03
JP4124820B2 (ja) 2008-07-23
PL334089A1 (en) 2000-01-31
JP2008120818A (ja) 2008-05-29
KR100479149B1 (ko) 2005-03-25
DE69736193D1 (de) 2006-08-03
EP0956296A2 (en) 1999-11-17
RU2179172C2 (ru) 2002-02-10
HUP0003396A3 (en) 2001-03-28
NZ335879A (en) 2000-11-24
BR9714376A (pt) 2000-03-21
MXPA99004944A (es) 2004-09-10
JP2001505580A (ja) 2001-04-24
HUP0003396A1 (hu) 2001-02-28
WO1998024807A3 (en) 1998-10-15
CA2274144A1 (en) 1998-06-11
KR20000069243A (ko) 2000-11-25
EP0956296B1 (en) 2006-06-21
AU7624898A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
ZA9710518B (en) Oxytocin heptapeptide analogues.
ZA972570B (en) Cement additives.
YU15299A (sh) Farmaceutski sastavi
EP0627232A3 (de) Steckverbindung.
EP0670413A3 (en) Quick connector for cementing head.
EP0977751A4 (en) SOMATOSTATIN AGONISTS
ZA974234B (en) Adhesion receptor antagonists.
ZA974147B (en) Somatostatin agonists and antagonists.
ZA986358B (en) Dolastatin 15 derivatives.
IL130166A0 (en) Somatostatin antagonists
EP0611047A3 (en) Improved centralized service circuit deployment.
ZA974333B (en) Beta-lactams.
ZA9711123B (en) Self service terminal.
EP1082126A4 (en) NEW PEPTIDES
ZA956812B (en) Excitatory amino acid receptor antagonists.
ZA971184B (en) Endothelin antagonists.
HK1019082A1 (en) Excavating tool.
ZA9710860B (en) Adhesives.
HK1014964A1 (en) Somatostatin peptides.
GB9718088D0 (en) Parallel isolated connection auxiliary (P.I.C.A.)
ZA981891B (en) Peptides useful as somatostatin antagonists.
ZA9710855B (en) Somatostatin antagonists.
NZ314277A (en) Octopeptide somatostatin antagonist
ZA983685B (en) Pregnanes.
ZA983706B (en) Pregnanes.